Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-14 4:42 pm Purchase |
2022-04-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Commodore Capital LP | 348,530 5.100% |
348,530 (New Position) |
Filing History |
| 2022-02-14 4:10 pm Purchase |
2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,711,286 11.800% |
502,525 (+15.66%) |
Filing History |
| 2022-02-14 4:09 pm Purchase |
2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
Commodore Capital LP | 3,079,756 5.400% |
208,132 (+7.25%) |
Filing History |
| 2022-02-14 4:08 pm Purchase |
2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Commodore Capital LP | 5,419,896 7.800% |
1,890,431 (+53.56%) |
Filing History |
| 2022-02-14 4:07 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 2,281,315 5.700% |
139,976 (+6.54%) |
Filing History |
| 2022-02-14 4:06 pm Purchase |
2021-12-31 | 13G | Celcuity Inc. CELC |
Commodore Capital LP | 920,464 6.200% |
89,497 (+10.77%) |
Filing History |
| 2022-02-14 4:04 pm Purchase |
2022-02-04 | 13G | BELLUS Health Inc. BLU |
Commodore Capital LP | 5,457,110 5.300% |
5,457,110 (New Position) |
Filing History |
| 2021-11-03 5:31 pm Purchase |
2021-10-07 | 13G | Cogent Biosciences, Inc. COGT |
Commodore Capital LP | 2,141,339 5.400% |
2,141,339 (New Position) |
Filing History |
| 2021-10-19 5:20 pm Purchase |
2021-10-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,208,761 10.200% |
1,089,516 (+51.41%) |
Filing History |
| 2021-07-12 2:44 pm Purchase |
2021-06-30 | 13G | CymaBay Therapeutics, Inc. CBAY |
Commodore Capital LP | 3,529,465 5.100% |
3,529,465 (New Position) |
Filing History |
| 2021-07-09 09:00 am Purchase |
2021-06-29 | 13G | Celcuity Inc. CELC |
Commodore Capital LP | 830,967 6.600% |
830,967 (New Position) |
Filing History |
| 2021-03-31 07:14 am Purchase |
2021-03-22 | 13G | Genocea Biosciences, Inc. GNCA |
Commodore Capital LP | 2,871,624 5.400% |
2,871,624 (New Position) |
Filing History |
| 2021-03-15 07:57 am Purchase |
2021-03-03 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 2,119,245 6.700% |
2,119,245 (New Position) |
Filing History |